Increasing Awareness of Healthcare and Growing Income Levels Drive Chinese Nutraceuticals Market
Increasing interest surrounding the benefits of nutraceuticals are driving their use in China. Government policies aimed at liberalizing previous restrictions on health food sales is helping to boost demand for nutraceuticals. Frost & Sullivan(http://www.food.frost.com/) research found that the Nutraceuticals Market in China was worth $12.5 billion in 2005.
"Nutraceuticals products have been seen as being able to alleviate some of the problems caused by an unbalanced diet," states Frost & SullivanProgramme Manager Kathy Brownlie.
As consumers become more health conscious, the government too has renewed focus on improving public health. Specific examples include: the finalization of the health food registration regulations in 2005, the establishing of clear measures for the examination and administration of health food advertisements, and ongoing efforts at obtaining regulatory approval for direct sales of health foods.
Read more...
A new science- Glycobiology has emerged! Eight specific sugars (glyconutrients) have been identified for the support of proper cell structures, processes, and functions (Harper's Biochemistry, 24th ed.). A blend of these eight innate-sugars from plant-rich sources has been developed, along with an entire line of products based on this amazing discovery! Are you ready to rediscover "wellness?"
Wednesday, May 24, 2006
Sunday, April 09, 2006
Glyconutrient Patent Successfully Enforced Against a Nutritional Supplements Firm Based in the United Kingdom
The patent has successfully been enforced against Bion/Elphanta, a nutritional supplements firm based in the United Kingdom. In an order filed with the High Court of Justice patents court in London, Bion agreed to stop breaching the U.K. patent on technology related to the glyconutritional blend, a unique glyconutritional formulation introduced in 1996. Bion also agreed to stop the manufacture, sales and importation of all dietary supplements related to glyconutrition "in any form and by any means."
Read more...
The patent has successfully been enforced against Bion/Elphanta, a nutritional supplements firm based in the United Kingdom. In an order filed with the High Court of Justice patents court in London, Bion agreed to stop breaching the U.K. patent on technology related to the glyconutritional blend, a unique glyconutritional formulation introduced in 1996. Bion also agreed to stop the manufacture, sales and importation of all dietary supplements related to glyconutrition "in any form and by any means."
Read more...
Saturday, March 25, 2006
Glyconutritionals to be available in Germany in April
The company that developed the Glyconutritional blend announced it will begin selling some of its glyconutritional products in Germany on April 3. The company's United Kingdom office will oversee sales and shipments to the new market. Germany is the third European Union country -- and the 10th country overall -- where Glyconutritional products are sold. In chronological order, the other countries are the United States, Canada, Australia, the United Kingdom, Japan, New Zealand, Republic of Korea, Taiwan and Denmark.
The company that developed the Glyconutritional blend announced it will begin selling some of its glyconutritional products in Germany on April 3. The company's United Kingdom office will oversee sales and shipments to the new market. Germany is the third European Union country -- and the 10th country overall -- where Glyconutritional products are sold. In chronological order, the other countries are the United States, Canada, Australia, the United Kingdom, Japan, New Zealand, Republic of Korea, Taiwan and Denmark.
Saturday, January 21, 2006
Proposed European Legislation on Claims to hit Functional Food, Nutraceuticals and Dietary Supplements industry
The growing number of health claims made on foods and the increasing incidence of obesity and non-communicable diseases in Europe have united the Member States of the European Union around new legislation on nutrition and health claims. This proposal, which was met with mixed emotions by the food industry, will fundamentally change the way in which many functional foods, nutraceuticals and dietary supplements are marketed in the EU. While the proposal will create a centralised pre-marketing authorisation procedure and make Reduction of Disease Risk Claims possible, it is expected to drive from products many of the lower level claims currently in use.
While the draft has been welcomed by some of the larger multi-national food companies many smaller businesses are still largely unaware of the tidal wave that is going to hit them when this legislation comes into force.
Read More...
The growing number of health claims made on foods and the increasing incidence of obesity and non-communicable diseases in Europe have united the Member States of the European Union around new legislation on nutrition and health claims. This proposal, which was met with mixed emotions by the food industry, will fundamentally change the way in which many functional foods, nutraceuticals and dietary supplements are marketed in the EU. While the proposal will create a centralised pre-marketing authorisation procedure and make Reduction of Disease Risk Claims possible, it is expected to drive from products many of the lower level claims currently in use.
While the draft has been welcomed by some of the larger multi-national food companies many smaller businesses are still largely unaware of the tidal wave that is going to hit them when this legislation comes into force.
Read More...
Saturday, January 07, 2006
Indiana University Set Up Sugar Center
Indiana University researchers will develop a new center to investigate sugar's role in such health issues as alcoholism and cancer, with the help of $3.2 million from the National Institutes of Health.
IU Bloomington chemist Milos Novotny and colleagues in the Department of Chemistry, School of Medicine and School of Informatics will establish the National Center for Glycomics and Glycoproteomics.
Many of Novotny's current research projects involve the attachment of sugars to large molecules inside the human body. The sugar chains serve several functions. Among them are acting as "tags" to put the body's immune system at ease and playing a role in alcoholism and some types of cancer.
Glycomics is the general study of these sugar chains. Glycoproteomics examines differences in the way the sugar chains are attached to proteins.
Staff at the center will create new technologies to improve the ability of scientists to investigate biological sugars, leading to a better understanding of sugar biology. Staff also will handle investigations of glycoprotein markers associated with cancer and alcoholism, endocrinology-center studies including fertilization, and comparative research about plants and animals.
-- Barb Berggoetz
Indiana University researchers will develop a new center to investigate sugar's role in such health issues as alcoholism and cancer, with the help of $3.2 million from the National Institutes of Health.
IU Bloomington chemist Milos Novotny and colleagues in the Department of Chemistry, School of Medicine and School of Informatics will establish the National Center for Glycomics and Glycoproteomics.
Many of Novotny's current research projects involve the attachment of sugars to large molecules inside the human body. The sugar chains serve several functions. Among them are acting as "tags" to put the body's immune system at ease and playing a role in alcoholism and some types of cancer.
Glycomics is the general study of these sugar chains. Glycoproteomics examines differences in the way the sugar chains are attached to proteins.
Staff at the center will create new technologies to improve the ability of scientists to investigate biological sugars, leading to a better understanding of sugar biology. Staff also will handle investigations of glycoprotein markers associated with cancer and alcoholism, endocrinology-center studies including fertilization, and comparative research about plants and animals.
-- Barb Berggoetz
Subscribe to:
Posts (Atom)